🇺🇸 FDA
Patent

US 10100317

Compositions of matter that reduce pain, shock, and inflammation by blocking linoleic acid metabolites and uses thereof

granted A61KA61K31/192A61K31/56

Quick answer

US patent 10100317 (Compositions of matter that reduce pain, shock, and inflammation by blocking linoleic acid metabolites and uses thereof) held by The Board of Regents of the University of Texas System expires Mon Oct 11 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Board of Regents of the University of Texas System
Grant date
Tue Oct 16 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Oct 11 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
15
CPC classes
A61K, A61K31/192, A61K31/56, A61K31/7088, A61K45/06